John Berdahl, MD
Show Description +
John P. Berdahl, MD, shares insights into the development of the MKO Melt (midazolam, ketamine, and ondansetron) compounded conscious sedation formulation, which is administered sublingually to sedate patients undergoing ocular and other surgical procedures. Dr. Berdahl explains how the MKO Melt, in troche format, provides a reliable and consistent level of sedation and allows for quick and easy administration, resulting in a more positive experience for both patients and staff.
Posted: 4/29/2016
John Berdahl, MD
John P. Berdahl, MD, shares insights into the development of the MKO Melt (midazolam, ketamine, and ondansetron) compounded conscious sedation formulation, which is administered sublingually to sedate patients undergoing ocular and other surgical procedures. Dr. Berdahl explains how the MKO Melt, in troche format, provides a reliable and consistent level of sedation and allows for quick and easy administration, resulting in a more positive experience for both patients and staff.
Posted: 4/29/2016
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASCRS: 2016.
Please log in to leave a comment.